For changes in serologic parameters during the 12 weeks of treatment, Group II showed a trend toward improving metabolic status, such as glucose and lipid profiles, but there were no changes in Group I compared to baseline status ( Table 1 ).
← all excerpts
Exercise improves the effects of testosterone replacement therapy and the durability of response after cessation of treatment: a pilot randomized controlled trial.
1
—
—